January 2014 - Volume 29 - Issue 1 - Contributor Index

Alphabetical Search
H
I
K
N
O
Q
U
W
X
Y
Z

Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment

Bauer, Michael; Demyttenaere, Koen; El-Khalili, Nizar; More

International Clinical Psychopharmacology . 29(1):16-25, January 2014.

Author:
Szamosi, Johan

Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment

Bauer, Michael; Demyttenaere, Koen; El-Khalili, Nizar; More

International Clinical Psychopharmacology . 29(1):16-25, January 2014.

Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study

Alam, Mohammed Y.; Jacobsen, Paula L.; Chen, Yinzhong; More

International Clinical Psychopharmacology . 29(1):36-44, January 2014.

Author:
Ruth, Adam C.

The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind,...

Montgomery, Stuart A.; Mansuy, Lucilla; Ruth, Adam C.; More

International Clinical Psychopharmacology . 29(1):26-35, January 2014.

Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment

Bauer, Michael; Demyttenaere, Koen; El-Khalili, Nizar; More

International Clinical Psychopharmacology . 29(1):16-25, January 2014.

The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind,...

Montgomery, Stuart A.; Mansuy, Lucilla; Ruth, Adam C.; More

International Clinical Psychopharmacology . 29(1):26-35, January 2014.

Author:
Mansuy, Lucilla

The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind,...

Montgomery, Stuart A.; Mansuy, Lucilla; Ruth, Adam C.; More

International Clinical Psychopharmacology . 29(1):26-35, January 2014.

Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study

Alam, Mohammed Y.; Jacobsen, Paula L.; Chen, Yinzhong; More

International Clinical Psychopharmacology . 29(1):36-44, January 2014.

Author:
Ma, Yi-Wen
Author:
Li, Dayong

The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind,...

Montgomery, Stuart A.; Mansuy, Lucilla; Ruth, Adam C.; More

International Clinical Psychopharmacology . 29(1):26-35, January 2014.

Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study

Alam, Mohammed Y.; Jacobsen, Paula L.; Chen, Yinzhong; More

International Clinical Psychopharmacology . 29(1):36-44, January 2014.

Author:
Gommoll, Carl

The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind,...

Montgomery, Stuart A.; Mansuy, Lucilla; Ruth, Adam C.; More

International Clinical Psychopharmacology . 29(1):26-35, January 2014.

Author:
Fu, Dong-Jing
Author:
Eriksson, Hans

Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment

Bauer, Michael; Demyttenaere, Koen; El-Khalili, Nizar; More

International Clinical Psychopharmacology . 29(1):16-25, January 2014.

Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment

Bauer, Michael; Demyttenaere, Koen; El-Khalili, Nizar; More

International Clinical Psychopharmacology . 29(1):16-25, January 2014.

Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment

Bauer, Michael; Demyttenaere, Koen; El-Khalili, Nizar; More

International Clinical Psychopharmacology . 29(1):16-25, January 2014.

Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment

Bauer, Michael; Demyttenaere, Koen; El-Khalili, Nizar; More

International Clinical Psychopharmacology . 29(1):16-25, January 2014.

Author:
Chen, Yinzhong

Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study

Alam, Mohammed Y.; Jacobsen, Paula L.; Chen, Yinzhong; More

International Clinical Psychopharmacology . 29(1):36-44, January 2014.

Author:
Bauer, Michael

Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment

Bauer, Michael; Demyttenaere, Koen; El-Khalili, Nizar; More

International Clinical Psychopharmacology . 29(1):16-25, January 2014.

Author:
Alphs, Larry

Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study

Alam, Mohammed Y.; Jacobsen, Paula L.; Chen, Yinzhong; More

International Clinical Psychopharmacology . 29(1):36-44, January 2014.